526 related articles for article (PubMed ID: 32392545)
21. Chondroitin sulfate-capped super-paramagnetic iron oxide nanoparticles as potential carriers of doxorubicin hydrochloride.
Mallick N; Anwar M; Asfer M; Mehdi SH; Rizvi MMA; Panda AK; Talegaonkar S; Ahmad FJ
Carbohydr Polym; 2016 Oct; 151():546-556. PubMed ID: 27474599
[TBL] [Abstract][Full Text] [Related]
22. Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
Zarrin A; Sadighian S; Rostamizadeh K; Firuzi O; Hamidi M; Mohammadi-Samani S; Miri R
Int J Pharm; 2016 Mar; 500(1-2):62-76. PubMed ID: 26721723
[TBL] [Abstract][Full Text] [Related]
23. Enhanced bio-compatibility of ferrofluids of self-assembled superparamagnetic iron oxide-silica core-shell nanoparticles.
Narayanan TN; Mary AP; Swalih PK; Kumar DS; Makarov D; Albrecht M; Puthumana J; Anas A; Anantharaman MR
J Nanosci Nanotechnol; 2011 Mar; 11(3):1958-67. PubMed ID: 21449334
[TBL] [Abstract][Full Text] [Related]
24. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
[TBL] [Abstract][Full Text] [Related]
25. Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy.
Scialabba C; Licciardi M; Mauro N; Rocco F; Ceruti M; Giammona G
Eur J Pharm Biopharm; 2014 Nov; 88(3):695-705. PubMed ID: 25281781
[TBL] [Abstract][Full Text] [Related]
26. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.
Wahajuddin ; Arora S
Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170
[TBL] [Abstract][Full Text] [Related]
27. Theranostic magnetite cluster@silica@albumin double-shell particles as suitable carriers for water-insoluble drugs and enhanced T2 MR imaging contrast agents.
Maboudi SA; Shojaosadati SA; Aliakbari F; Arpanaei A
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1485-1492. PubMed ID: 30889683
[TBL] [Abstract][Full Text] [Related]
28. Magnetic core-shell hybrid nanoparticles for receptor targeted anti-cancer therapy and magnetic resonance imaging.
Shanavas A; Sasidharan S; Bahadur D; Srivastava R
J Colloid Interface Sci; 2017 Jan; 486():112-120. PubMed ID: 27697648
[TBL] [Abstract][Full Text] [Related]
29. Investigation of the factors affecting the photothermal therapy potential of small iron oxide nanoparticles over the 730-840 nm spectral region.
Bilici K; Muti A; Demir Duman F; Sennaroğlu A; Yağcı Acar H
Photochem Photobiol Sci; 2018 Nov; 17(11):1787-1793. PubMed ID: 30168556
[TBL] [Abstract][Full Text] [Related]
30. Gated magnetic mesoporous silica nanoparticles for intracellular enzyme-triggered drug delivery.
An N; Lin H; Yang C; Zhang T; Tong R; Chen Y; Qu F
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():292-300. PubMed ID: 27612716
[TBL] [Abstract][Full Text] [Related]
31. Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells.
Cicha I; Scheffler L; Ebenau A; Lyer S; Alexiou C; Goppelt-Struebe M
Nanotoxicology; 2016; 10(5):557-66. PubMed ID: 26468004
[TBL] [Abstract][Full Text] [Related]
32. Mesoporous γ-Iron Oxide Nanoparticles for Magnetically Triggered Release of Doxorubicin and Hyperthermia Treatment.
Benyettou F; Ocadiz Flores JA; Ravaux F; Rezgui R; Jouiad M; Nehme SI; Parsapur RK; Olsen JC; Selvam P; Trabolsi A
Chemistry; 2016 Nov; 22(47):17020-17028. PubMed ID: 27739116
[TBL] [Abstract][Full Text] [Related]
33. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
34. Doxorubicin-loaded magnetic gold nanoshells for a combination therapy of hyperthermia and drug delivery.
Mohammad F; Yusof NA
J Colloid Interface Sci; 2014 Nov; 434():89-97. PubMed ID: 25170601
[TBL] [Abstract][Full Text] [Related]
35. Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).
Shevtsov M; Nikolaev B; Marchenko Y; Yakovleva L; Skvortsov N; Mazur A; Tolstoy P; Ryzhov V; Multhoff G
Int J Nanomedicine; 2018; 13():1471-1482. PubMed ID: 29559776
[TBL] [Abstract][Full Text] [Related]
36. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy.
Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY
Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205
[TBL] [Abstract][Full Text] [Related]
38. The impact of polymer coatings on magnetite nanoparticles performance as MRI contrast agents: a comparative study.
Khalkhali M; Rostamizadeh K; Sadighian S; Khoeini F; Naghibi M; Hamidi M
Daru; 2015 Sep; 23(1):45. PubMed ID: 26381740
[TBL] [Abstract][Full Text] [Related]
39. Theranostic nanoparticles based on magnetic nanoparticles: design, preparation, characterization, and evaluation as novel anticancer drug carrier and MRI contrast agent.
Nosrati H; Salehiabar M; Kheiri Manjili H; Davaran S; Danafar H
Drug Dev Ind Pharm; 2018 Oct; 44(10):1668-1678. PubMed ID: 29848101
[TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
Elbialy NS; Fathy MM; Khalil WM
Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]